The NHS is preparing to expand access to cholesterol testing through community pharmacies in England, with around 100 sites set to begin offering life-saving checks this autumn. The move is part of a broader effort to reduce heart disease and stroke deaths by a quarter over the next decade, according to NHS England.
High-street pharmacies to play a bigger role in prevention
The new service is designed to make screening more convenient for patients who may not otherwise seek testing in a traditional clinical setting. By shifting part of cardiovascular prevention into pharmacies, the NHS is aiming to identify people at risk earlier and encourage faster follow-up where needed.
NHS England said the initiative forms part of a drive to lower deaths from heart disease and stroke over the next 10 years. The organisation also highlighted other recent service developments, including cancer-drug approvals for rare blood cancers and wider seasonal vaccination activity, as it continues to push prevention alongside treatment.
Part of a wider prevention strategy
The rollout comes after a summer in which the health service has been under intense operational pressure, but has still reported gains in some areas of performance. NHS England said A&E demand hit record levels in July amid heatwaves, while planned-care performance improved to its best level against the 18-week target in nearly five years.
That backdrop gives added weight to efforts that can reduce future demand on hospitals. If the pharmacy checks help detect raised cholesterol earlier, patients could be directed to treatment and lifestyle support before their risk develops into a more serious event. That inference follows from the NHS’s stated prevention goal and the service’s focus on early identification.
For patients, the change could mean quicker access to testing in familiar community settings, closer to where they live and shop. For the health service, it represents another attempt to move care upstream, with prevention and convenience working together to ease the long-term burden of cardiovascular disease.
Photo source: AI-generated or edited image


